|
|
Melanocyte Stimulating Hormones and Their Receptors
Sponsored by the APS Water & Electrolyte
Homeostasis Section
Tues. April 4—8:00-10:00 AM
|
| Chaired: |
Michael H. Humphreys,
Univ. of California, San Francisco |
Melanocyte stimulating
hormones (MSHs) are peptides of α-, β-, and γ primary structure derived from
the ACTH-β-endorphin precursor proopiomelanocortin (POMC). Initially
identified by the property of α- and β-MSH to induce melanin dispersion in
skin of amphibians and reptiles, a broad array of other functions has been
recognized for these peptides through the identification of a family of five
melanocortin receptors. These receptors are members of the G
protein-coupled receptor family and signal through activation of adenylate
cyclase and stimulation of cyclic adenosine-3’,-5’-monophosphate
production. The action of MSH’s was originally thought to reflect the
function of an endocrine system in which pituitary POMC was processed into
the peptides, which were then secreted into the circulation. However,
current evidence indicates that POMC is expressed in numerous regions of the
central nervous system and in other tissues, and that MSH peptides exert
many of their effects locally. This symposium will present the latest
information on these peptides, their receptors, and their physiologic
actions. The initial presentation will describe the regulation of POMC
processing in its major sites of expression. The next talk will
characterize the features of the melanocortin receptors and their signaling
pathways. Subsequent presentations will review the effects of MSH peptides
on energy metabolism and the development of obesity, and on cardiovascular
and renal function and the regulation of blood pressure. This symposium
will provide listeners with a broad overview of the actions of MSH peptides
acting through their receptors and point to exciting avenues for future
research.
|
8:00 AM |
Tissue expression and processing of proopiomelanocortin.
Donald F. Steiner, Univ. of Chicago
|
|
8:30 AM |
Human genetics of the melanocortin-4 receptor.
Christian Vaisse, Univ. of California, San Francisco
|
|
9:00 AM |
Hypothalamic melanocortins, sympathetic activation and
obesity hypertension.
John E. Hall, Univ. of Mississippi Med. Ctr.
|
|
9:30 AM |
Cardiovascular Actions of
MSH Peptides.
Michael H. Humphreys, Univ. of California, San Francisco |
|
|